| Disruption of the MMAC1/PTEN Gene by Deletion or Mutation Is a Frequent Event in Malignant Melanoma P Guldberg, P thor Straten, A Birck, V Ahrenkiel, AF Kirkin, J Zeuthen Cancer research 57 (17), 3660-3663, 1997 | 620 | 1997 |
| Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia E Klein, F Vánky, H Ben‐Bassat, H Neumann, P Ralph, J Zeuthen, ... International journal of cancer 18 (4), 421-431, 1976 | 584 | 1976 |
| Somatic Fas Mutations in Non-Hodgkin’s Lymphoma: Association With Extranodal Disease and Autoimmunity K Grønbæk, P Straten, E Ralfkiaer, V Ahrenkiel, MK Andersen, ... Blood, The Journal of the American Society of Hematology 92 (9), 3018-3024, 1998 | 399 | 1998 |
| The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis J Bartkova, J Lukas, P Guldberg, J Alsner, AF Kirkin, J Zeuthen, J Bartek Cancer Research 56 (23), 5475-5483, 1996 | 374 | 1996 |
| Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody LS Nielsen, JG Hansen, L Skriver, EL Wilson, K Kaltoft, J Zeuthen, ... Biochemistry 21 (25), 6410-6415, 1982 | 324 | 1982 |
| Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells ACP Diederichsen, J v B Hjelmborg, PB Christensen, J Zeuthen, ... Cancer Immunology, Immunotherapy 52, 423-428, 2003 | 312 | 2003 |
| Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. EM Salonen, O Saksela, T Vartio, A Vaheri, LS Nielsen, J Zeuthen Journal of Biological chemistry 260 (22), 12302-12307, 1985 | 245 | 1985 |
| Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies A Birck, V Ahrenkiel, J Zeuthen, K Hou-Jensen, P Guldberg Journal of Investigative Dermatology 114 (2), 277-280, 2000 | 201 | 2000 |
| Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide M Röpke, J Hald, P Guldberg, J Zeuthen, L Nørgaard, L Fugger, ... Proceedings of the National Academy of Sciences 93 (25), 14704-14707, 1996 | 195 | 1996 |
| Characterization of a human ovarian teratocarcinoma‐derived cell line J Zeuthen, JOR Nørgaard, P Avner, M Fellous, J Wartiovaara, A Vaheri, ... International Journal of Cancer 25 (1), 19-32, 1980 | 185 | 1980 |
| Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL MH Andersen, JE Bonfill, A Neisig, G Arsequell, I Søndergaard, J Neefjes, ... The Journal of Immunology 163 (7), 3812-3818, 1999 | 171 | 1999 |
| Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma P Guldberg, V Ahrenkiel, T Seremet, AF Kirkin, J Zeuthen Oncogene 18 (9), 1777-1780, 1999 | 145 | 1999 |
| Generation of a Murine Monoclonal Antibody Specific for N-Glycolylneuraminic Acid-Containing Gangliosides That Also Recognizes Sulfated Glycolipids AM Vazquez, M Alfonso, B Lanne, KA Karlsson, A Carr, O Barroso, ... Hybridoma 14 (6), 551-556, 1995 | 133 | 1995 |
| Escape from host-antitumor immunity G Pawelec, J Zeuthen, R Kiessling Critical Reviews™ in Oncogenesis 8 (2-3), 1997 | 126 | 1997 |
| Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo JS Haurum, IB Høier, G Arsequell, A Neisig, G Valencia, J Zeuthen, ... The Journal of experimental medicine 190 (1), 145-150, 1999 | 120 | 1999 |
| Melanoma‐associated antigens recognized by cytotoxic T lymphocytes AF KIRKIN, K DZHANDZHUGAZYAN, J ZEUTHEN Apmis 106 (7‐12), 665-679, 1998 | 115 | 1998 |
| Ecto‐ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas KN Dzhandzhugazyan, AF Kirkin, P thor Straten, J Zeuthen FEBS letters 430 (3), 227-230, 1998 | 111 | 1998 |
| Accumulation of identical T cells in melanoma and vitiligo-like leukoderma JC Becker, P Guldberg, J Zeuthen, EB Bröcker, P thor Straten Journal of investigative dermatology 113 (6), 1033-1038, 1999 | 110 | 1999 |
| Identification of an Epstein‐Barr virus‐coded thymidine kinase. E Littler, J Zeuthen, AA McBride, E Trøst Sørensen, KL Powell, ... The EMBO Journal 5 (8), 1959-1966, 1986 | 107 | 1986 |
| Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules MH Andersen, L Tan, I Søndergaard, J Zeuthen, T Elliott, JS Haurum Tissue Antigens 55 (6), 519-531, 2000 | 103 | 2000 |
Anders RosénProfessor at Linköping UniversityE-mail confirmado em liu.se
